Associate Professor Adam Irwin is an NHMRC Emerging Leadership Fellow and Associate Professor in Infectious Diseases at the University of Queensland (UQ) and Queensland Children’s Hospital. He holds positions within the UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences. His work focuses on early sepsis recognition, antimicrobial stewardship, and pediatric infectious diseases. Dr. Irwin completed his medical degree at the University of Birmingham and his PhD in 2016 from the University of Liverpool’s Institute of Infection and Global Health. He has led initiatives like the Queensland Paediatric Sepsis Program, recognized with a Global Sepsis Alliance Award and Queensland Health Excellence Awards. His research spans sepsis pathway implementation, antimicrobial resistance trends, and rapid diagnostic tools. Notable grants include NHMRC funding for studies on multi-drug resistant infections and Children’s Hospital Foundation support for genomics and antimicrobial stewardship projects. He supervises PhD candidates in areas like bloodstream infections and molecular diagnostics. Dr. Irwin collaborates across institutions, contributing to projects such as the RAPIDS Study Group and the PAEDS surveillance network. Awards include the NHMRC Emerging Leadership Fellowship and recognition for sepsis program excellence. His work emphasizes translating research into clinical practice, improving outcomes for critically ill children through evidence-based protocols and innovative diagnostics.
Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.
Massimo Piccardi is a Professor of Natural Language Processing (NLP), Computer Vision, and Machine Learning at the University of Technology Sydney (UTS) , where he has been since 2002. He currently serves as the Head of the School of Electrical and Data Engineering and leads the Big Data Analytics program at the Global Big Data Technologies Centre. His research focuses on advancing NLP, machine learning applications in healthcare, and cybersecurity in IoT systems. He has authored over 200 journal papers and conference proceedings, secured significant ARC and CRC grants, and holds the IEEE Computer Society Distinguished Contributor Award (2022). Education & Professional Roles: Joined UTS in 2002, progressing from Associate Professor (2002–2007) to Professor (2008–present). Serves as Associate Editor for IEEE Transactions on Big Data and Editor for Artificial Intelligence in Medicine. Active in professional societies including IEEE, ACL, and ALTA (President, 2023–2024). Research Interests: Core areas include NLP (translation, summarization, adversarial attacks), healthcare informatics (clinical NLP, health service analysis), and cybersecurity (IoT security, privacy-preserving systems). Cross-cutting themes include generative models, cross-lingual systems, and ethical AI. Grants & Projects: Principal Investigator on ARC Discovery/Linkage projects and CRC grants. Recent projects include controllable machine translation (Amazon), privacy-preserving digital agriculture, and STEM innovation (ASTRID project with NBN Co). Labs & Collaborations: Leads the UTS Global Big Data Technologies Centre, collaborating on projects like adversarial NLP attacks, medical machine translation, and secure IoT frameworks.
Professor Shaun Larkin is a part-time academic at the School of Public Health , University of Sydney, specializing in Health Policy and Financing . He is affiliated with the Leeder Centre for Health Policy, Economics and Data and a member of the Charles Perkins Centre . With a career spanning executive roles at HCF and non-executive directorships in health startups, his work bridges academia and industry. Education : Harvard Business School alumnus with a HlthScD, MBA, MHSc, and BHA. His research focuses on health economics , health policy , and health services management , emphasizing: Translational research in healthcare financing Trends in private-public healthcare partnerships Price transparency in private health insurance Leadership in health systems Chronic disease management Quality use of medicines His publications reveal a trajectory from foundational work in: Psychiatric services data standardization (2000) Heart disease and diabetes management (2013-2015) Telehealth interventions (2017-2018) Private sector policy frameworks (2019-2020) Saudi Arabian health reforms (2022-present) Private equity in healthcare (2025) As an advisor, he currently supervises research students on topics including: Quality use of medicines in Saudi Arabia Sustainable financial models for private hospitals Patient-reported outcome measures in Australia He also contributes to the Leeder Centre and engages with global health startups as an investor and advisor.
Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.
Lisa L. Wynn is Professor in the School of Social Sciences (Discipline of Anthropology) at Macquarie University in Sydney, Australia. She serves as Associate Editor of American Ethnologist (2022-2027) and previously held leadership positions including President of the Australian Anthropological Society (2020) and membership on the AAS Executive Committee (2018-2021). Wynn earned her PhD in 2003 from Princeton University's Anthropology Department, followed by postdoctoral positions at Princeton's Office of Population Research and Center for Health and Wellbeing. Her research program centers on gender, reproductive health technologies, sexuality, and religion, with continuous fieldwork in Egypt since 1998. More recently, she has expanded her work to examine ethics review bureaucracies, lay understandings of infectious disease, and young adult vaping behaviors in Australia. Her methodological approach combines deep ethnographic engagement with critical analysis of how power structures intersect with medical technologies and bodily experiences, particularly among marginalized communities. Analysis of her recent publications reveals an evolving trajectory that maintains her foundational interest in Middle Eastern contexts while increasingly addressing digital spaces (as seen in studies of online fatwas) and contemporary health crises (including pandemic responses and vaping culture), with consistent attention to bodily autonomy and reproductive justice. Her significant scholarly contributions have been recognized through multiple prestigious awards: Vice Chancellor's Teaching Excellence Award from Macquarie University (2009) Australian Award for Teaching Excellence (2012) OLT National Teaching Fellowship (2012-2014) Leeds Honor Prize from the Society for Urban, National, and Transnational/Global Anthropology (2008) Wynn actively mentors graduate researchers specializing in gender, sexuality, medicine and technology, with particular emphasis on sexual and reproductive health. Her research program has received substantial funding from the Social Science Research Council, Australian Research Council, Office of Learning and Teaching, and Hort Innovation. Notably, she co-led a major international project to develop multilingual sexual and reproductive health resources that have reached millions of users across 208 countries. She also created a free online ethics training program for humanities and social sciences researchers at Macquarie University. Through collaborations with Cambridge Reproductive Health Consultants and other partners, Wynn has successfully translated academic research into accessible public resources, including evidence-based information on medication abortion available in six languages (English, Spanish, French, Arabic, Turkish, and Farsi).
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Associate Professor Marcus Cattani is a faculty member at Edith Cowan University (ECU), affiliated with the School of Medical and Health Sciences and the Department of Occupational Health and Safety. He serves as Deputy Director of the WA Government-funded MARS Centre, focusing on Mental Awareness, Respect, and Safety initiatives. Since joining ECU in 2015, he has developed risk management and leadership programs for undergraduate/postgraduate programs and supervises PhD/Master's research. His research emphasizes injury risk reduction in industries like mining, oil/gas, and construction, with recent focus on agriculture safety and radiation exposure in Western Australian mining. Education: Doctor of Philosophy (Occupational Health and Safety), Murdoch University (2004) Master of Science, United Kingdom (1995) Research interests include occupational safety frameworks, real-time exposure assessment, fatigue management, and safety leadership tools. Current projects address critical controls for construction fatalities, radiation exposure in mining, and OHS systems for remote work. Over 30 years of industry experience as an occupational hygienist and HSE consultant informs his academic and applied work. Key collaborations involve government agencies (DMIRS, Water Corporation) and industry partners (Rio Tinto, Lifeline WA). Recent grants include MARS Centre initiatives and NORM exposure studies. His 2025 focus includes translating injury prevention techniques into agriculture contexts. Professional memberships include Australian Institute of Health and Safety (Chartered OHS Professional) and the Australian Institute of Occupational Hygienists.
Dr. Suresh Bhargava is a Distinguished Professor and Director of AcSIR at RMIT University's Research & Innovation department. He has led interdisciplinary research in materials science, catalysis, and environmental engineering for over three decades, with a focus on strengthening Indo-Australian scientific collaboration. His work bridges academia and industry, addressing challenges in pollution control, nanotechnology, and cancer treatment. Research & Leadership: Established RMIT's Centre for Advanced Materials and Industrial Chemistry (CAMIC), pioneering translational research with industry applications. Supervised 70+ PhD students (100% employment rate), many now leading roles at global institutions. Holds distinguished professorships across six countries and advises governments and Fortune 500 firms on environmental and industrial issues. Awards & Recognition: Recipient of Australia's Member of the Order of Australia (2022), India's P.C. Ray Chair (2014), and the Khwarizmi International Award (2016). His work on mercury pollution control and gold-based anticancer drugs has garnered global acclaim, with over 800 publications (26,000+ citations, h-index 86). Key Contributions: Architect of the Australia-India Strategic Research Fund and the RMIT-AcSIR Joint Research Program. Innovated eco-friendly graphene production from eucalyptus bark and patented anti-cancer gold compounds. Advises on sustainable mineral processing, hydrogen energy, and CO₂ valorization. Industry Engagement: Consulted for Rio Tinto, BHP Billiton, and CSIRO on resource efficiency, pollution mitigation, and nanotechnology applications. His research has created jobs and driven innovation in Australia and Asia-Pacific.
Professor Gavan McNally is a distinguished behavioral neuroscientist at the University of New South Wales, where he serves as a Professor in the School of Psychology. He is actively engaged in research on the fundamental behavioral and brain mechanisms for learning and motivation, with applications to clinical conditions such as addictions, anxiety disorders, and mood disorders. McNally holds several prestigious editorial positions, including Editor-in-Chief of Neurobiology of Learning & Memory and Senior Editor of The Journal of Neuroscience. He also serves as President-Elect of the European Behavioral Pharmacology Society and is a Member of the Australian Research Council College of Experts. McNally's research interests span behavioral neuroscience, focusing on how fundamental brain mechanisms apply to clinical conditions. He employs a systems neuroscience approach, combining well-controlled behavioral approaches with optogenetics, chemogenetics, in vivo calcium imaging, and whole brain circuit mapping in both normal and transgenic animals. His work bridges basic science with clinical applications through collaborations with colleagues at University of Sydney, Sydney Local Health District, Monash University, and Turning Point. McNally's research particularly examines the cellular, circuit, and systems level mechanisms underlying learning, motivation, and their dysregulation in disorders like addiction. His laboratory investigates how these mechanisms translate to human conditions, with a strong emphasis on developing new treatments for psychological disorders. His extensive publication record demonstrates a clear trajectory in understanding punishment learning, addiction mechanisms, and the neural circuits underlying motivated behavior. Recent work has increasingly focused on the cognitive pathways to punishment insensitivity, the role of specific neural circuits in addiction, and translational approaches to understanding maladaptive behaviors. McNally's research bridges animal models with human studies, creating a comprehensive understanding of the neural mechanisms that govern learning and motivation, with particular attention to how these processes go awry in addiction and other psychological disorders. 2008 QEII Fellow, Australian Research Council 2009 Association for Psychological Science, International Rising Star 2010 Fellow, Association for Psychological Science 2010 UNSW Faculty of Science Staff Excellence Award for Research and Training 2011 Pavlovian Research Award, The Pavlovian Society 2012 Future Fellow (Level 3), Australian Research Council 2016 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association 2017 Fellow, American Psychological Association 2019 Fellow of the Academy of Social Sciences in Australia 2021 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association 2022 Ross Day Plenary Lecturer, Australasian Brain and Psychological Sciences 2023 European Behavioural Pharmacology Society Plenary Lecturer 2024 Elspeth McLachlan Plenary Lecturer, Australasian Neuroscience Society 2024 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association Professor McNally actively supervises several students including Bixuan Lin, Si Yin Lui, Hannah Machet, Bart Cooley, Kelly Zhuang, and Alexandra Gregory. His current research is supported by significant funding including an Australian Research Council Discovery Project (2024-2026) on "Risky choices: From cells and circuits to computations and behaviour," another Discovery Project (2025-2028) on "Multimodal mapping of punishment learning," and NHMRC grants including a Synergy Grant on "Linking clinical and basic science discovery to find new treatments for alcohol-use disorder" and an Ideas Grant on "Novel pathways to abstinence from alcohol seeking." These projects reflect his commitment to both fundamental neuroscience and translational applications for treating psychological conditions. His teaching responsibilities include PSYC2081 Learning & Physiological Psychology and PSYC3051 Physiological Psychology. McNally's laboratory employs advanced techniques including optogenetics, chemogenetics, in vivo calcium imaging, and whole brain circuit mapping to investigate the neural mechanisms underlying learning, motivation, and their dysregulation in disorders. His team works at the intersection of basic neuroscience and clinical applications, with strong collaborations across multiple institutions to translate fundamental findings into potential treatments for addiction and other psychological disorders. The lab has made significant contributions to understanding the role of brain regions like the ventral pallidum, paraventricular thalamus, and nucleus accumbens in addiction, fear learning, and punishment sensitivity.
Adrian Linacre is a Professor and Chair in Forensic DNA Technology at Flinders University, within the College of Science and Engineering, Department of Biological Sciences. He is a leading figure in forensic science, with a focus on DNA analysis, wildlife forensics, and crime scene investigation. BSc in Biological Sciences (Hons), University of Edinburgh, 1984 DPhil in Molecular Genetics, University of Sussex, 1988 His research centers on getting more from less at crime scenes , particularly through developing highly sensitive DNA typing methods and studying the transfer and persistence of biological materials. He also pioneers the use of non-human DNA in forensic investigations, notably in wildlife forensic science , aiding in species identification and combating illegal wildlife trade. His recent publications reflect a strong trend in trace DNA analysis , body fluid identification , and DNA transfer dynamics , with applications in drug cases, sexual assault investigations, and environmental DNA degradation. His work increasingly integrates molecular techniques with real-world forensic challenges. Notable scientific awards include: Medal of the Order of Australia (OAM), 2020 Inspirational Scientist of the Year, Royal Society of Edinburgh, 2005 Fellow of the Royal Society for the Encouragement of Arts and Commerce (FRSA) Finalist, South Australian Science Excellence and Innovation Awards (2023, 2024) He has successfully supervised several students, including Piyamas Kanokwongnuwut and Alicia Haines, many of whom have won international recognition. He has secured significant research funding and contributed to national and international forensic policy, including a key review for the UK Home Office on low-template DNA. His professional leadership includes presidencies of the ANZFSS and ISFG, and vice presidency of the IAFS. Linacre is actively involved in editorial roles, serving as Associate Editor for Forensic Science International: Genetics and on the boards of Forensic Science, Medicine and Pathology and the Australian Journal of Forensic Science . He is a sought-after expert witness and media commentator in forensic science.
Prof. Ivan Cole is an Adjunct Professor at RMIT University's School of Engineering, specializing in rapid materials discovery for corrosion protection, nanostructures, and additive manufacturing. His work integrates computational modeling with high-throughput experimentation, focusing on corrosion inhibitors, biocompatible surfaces, and additive manufacturing process optimization. With over 30 years of experience across academia and industry (including leadership roles at CSIRO and Centro-Svilluppo Materiali), he leads the Rapid Discovery & Fabrication Team (RDF) to advance these research areas. Research Interests: Corrosion science, microbially induced corrosion (MIC), additive manufacturing surfaces, nanostructure sensing, multiscale modeling, and green materials discovery. His team addresses challenges in corrosion protection, biomedical implants, and environmental remediation through innovative methodologies. Awards: 2019 Australian Corrosion Medal 2016 CSIRO Lifetime Achievement Award 2013 Best Paper in NACE Corrosion Supervision & Projects: Active in mentoring PhD/Master’s students across corrosion inhibition, additive manufacturing, and nanostructure design. Notable projects include developing quorum sensing inhibitors for biofilm control, in-situ monitoring for metal AM, and eco-friendly corrosion inhibitors. Labs & Collaborations: Leads the Rapid Discovery & Fabrication Team and collaborates with industry partners to translate research into practical solutions for materials durability and sustainability.
Emmanuel Stamatakis is a Professor of Physical Activity, Lifestyle, and Population Health at the University of Sydney's School of Health Sciences (Faculty of Medicine and Health). He holds NHMRC Leadership Fellowships (2021-2025 and 2026-2030) and leads the Charles Perkins Centre's Physical Activity & Exercise Theme. His research focuses on lifestyle behaviors' impacts on cardiometabolic conditions, cancer, and cardiovascular health, using large-scale cohort studies and wearable device data. Key roles include directing the Mackenzie Wearables Research Hub and co-chairing WHO's Physical Activity Guidelines Development Group. Education: PhD from University of Bristol (2003), post-doctoral training at University College London. He leads the ProPASS consortium, involving 45 cohorts with wearable data. Over 460 peer-reviewed publications, including Clarivate's Highly Cited list since 2019. Research interests integrate physical activity, sedentary behavior, and sleep analytics with clinical outcomes. Current projects explore wearables-based measurement innovations, SPAN (sleep-physical activity-nutrition) synergies, and intervention designs for GLP-1 receptor agonist users. Recent articles emphasize VILPA (vigorous intermittent lifestyle physical activity) benefits, sleep-cardiovascular links, and multimodal lifestyle optimization. Awards include Australia's Top Researcher in Sports Medicine and multiple NHMRC grants. Supervises PhD projects on physical activity measurement and intervention design. Active in 50+ peer-reviewed journals and national/international funding bodies.
Professor Chengzhong (Michael) Yu is a Research Professor at the Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland. His research focuses on functional nanomaterials for healthcare, energy, and environmental applications. He holds over 400 publications with 36,000+ citations and has received prestigious awards like the NHMRC Leadership Fellowship and ARC Future Fellowship. Education: PhD in Chemistry from Fudan University. Research Interests: Silica-based nanoparticles for drug/gene delivery, energy storage materials (e.g., aluminum-ion batteries), sustainable catalysis, and nano-pesticides for agriculture. His group develops biomaterials for cancer therapy, immunotherapy, and mRNA vaccine platforms. Recent Trends in Publications: Focused on advancing nanocarrier systems for therapeutics, electrocatalytic H₂O₂ synthesis from seawater, and sustainable energy solutions. Collaborates with industry partners like N4 Pharma and Baosteel for translational applications. Awards & Grants: Multiple ARC Discovery/Linkage grants, NHMRC funding, and industry partnerships totaling millions. Notable projects include mRNA delivery platforms and rechargeable aluminum-ion batteries. Supervision & Labs: Mentors over 20 PhD/Master’s students. Leads the Yu Group, collaborating on projects like ‘Designer Nanoparticles for mRNA Factories’ and ‘Nanotechnology for Flystrike Control in Livestock’.
Professor Bing-Jie (Bruce) Ni is an Adjunct Professor at the University of Technology Sydney (UTS) within the School of Civil and Environmental Engineering and a full Professor at UNSW Sydney. He is an internationally recognised leader in environmental engineering, wastewater treatment, greenhouse-gas mitigation, microplastics fate, electrocatalysis and sustainable energy systems. Education PhD in Environmental Engineering, University of Science and Technology of China, Hefei (2005–2009) Research Interests Professor Ni’s research integrates process engineering, microbial biotechnology, materials science and mathematical modelling to develop sustainable technologies for high-efficiency pollutant removal, minimal carbon footprint and maximal energy recovery from wastewater. He is a global pioneer in: Modelling and control of nitrous oxide (N₂O) and methane (CH₄) emissions from wastewater systems, Micro- and nano-plastics ecotoxicity and mitigation in anaerobic digestion, Transforming sewage sludge into high-value liquid bio-energy (medium-chain fatty acids and long-chain alcohols), Designing cost-effective electrocatalysts from natural minerals for green hydrogen production and wastewater electrolysis. Research Output & Impact Over the last decade he has published 2 research books, 30 book chapters and >400 refereed journal papers , including 35 in Environmental Science & Technology and 85 in Water Research . His work has influenced global policy: the IPCC adopted his nitrous-oxide-emission model in 2019 to revise national greenhouse-gas inventories for the first time in 13 years. Awards & Recognition ARC Future Fellowship & ARC DECRA Fellowship Clarivate Analytics Highly Cited Researcher (Web of Science) Royal Society of Chemistry Highly Cited Researcher (2020–present) Mendeley Data Top 2 % Cited Researchers worldwide Listed among “Australia’s Most Innovative Engineers” (Engineers Australia, 2018) 50+ additional awards including Scopus Young Researcher Award, South Australian Water Awards, UQ Research Excellence Awards, and Outstanding Doctoral Dissertation Awards. Research Funding & Leadership He has secured ≈ AUD $10 million in competitive funding (six major ARC grants plus >20 government, university and industry projects). He serves as: Lead Guest Editor, Water Research Editorial Advisory Board, Environmental Science & Technology Associate Editor for Journal of Cleaner Production , Environmental Chemistry Letters , Environmental Research , Journal of Environmental Management Editorial Board member for five additional high-impact journals. Teaching & Supervision At UTS he teaches Renewable Energy Technologies , Environmental and Sanitation Engineering , Process Dynamics and Control , and Water and Wastewater Treatment . He is available to supervise Masters and PhD students in environmental biotechnology, process modelling and sustainable energy systems. Laboratory & Commercial Translation He heads active research teams at both UNSW and UTS and is the inventor of >10 granted patents , some of which are currently being commercialised to deliver real-world impacts in greenhouse-gas-neutral wastewater treatment and renewable energy production.
